Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global ED Treatment market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global ED Treatment market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Sildenafil Tadalafil Others Segmented by End User/Segment Hospitals Drugstores Other Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Teva Pharma Seoul Pharma S.K. Chemicals Pfizer Metuchen Pharma Eli Lilly Dong-A ST CSBIO. Bayer BaiYunShan General Factory

List of Tables

Table Global ED Treatment Sales Value and CAGR by Region (2016-2027)
Table Global ED Treatment Sales Volume by Company (2019-2021)
Table Global ED Treatment Sales Volume Market Share by Company (2019-2021)
Table Global ED Treatment Sales Value by Company (2019-2021)
Table Global ED Treatment Sales Value and CAGR by Region (2016-2027)
Table Global ED Treatment Price by Company (2019-2021)
Table Main Manufacturers ED Treatment Product Location and Sales Area
Table Global ED Treatment Sales Value by Company (2019-2021)
Table Global ED Treatment Sales Volume by Category (2016-2021)
Table Global ED Treatment Sales Volume Market Share by Category (2016-2021)
Table Global ED Treatment Sales Value by Category (2016-2021)
Table Global ED Treatment Sals Value Market Share by Category (2016-2021)
Table Global ED Treatment Price by Category (2016-2021)
Table North America ED Treatment Sales Volume by Category (2016-2021)
Table Global ED Treatment Sales Value by Category (2016-2021)
Table Europe ED Treatment Sales Volume by Category (2016-2021)
Table Europe ED Treatment Sales Volume Market Share by Category (2016-2021)
Table Asia Pacific ED Treatment Sales Volume by Category (2016-2021)
Table Asia Pacific ED Treatment Sales Volume Market Share by Category (2016-2021)
Table Central & South America ED Treatment Sales Volume by Category (2016-2021)
Table Central & South America Pacific ED Treatment Sales Volume Market Share by Category (2016-2021)
Table Middle East & Africa ED Treatment Sales Volume by Category (2016-2021)
Table Middle East & Africa ED Treatment Sales Volume Market Share by Category (2016-2021)
Table Global ED Treatment Sales Volume by End User/Segment (2016-2021)
Table Global ED Treatment Sales Volume Market Share by End User/Segment (2016-2021)
Table Global ED Treatment Sales Value by End User/Segment (2016-2021)
Table Global ED Treatment Value Market Share by End User/Segment (2016-2021)
Table Global ED Treatment Price by End User/Segment (2016-2021)
Table North America ED Treatment Sales Volume by End User/Segment (2016-2021)
Table Global ED Treatment Sales Value by End User/Segment (2016-2021)
Table Europe ED Treatment Sales Volume by End User/Segment (2016-2021)
Table Europe ED Treatment Sales Volume Market Share by End User/Segment (2016-2021)
Table Asia Pacific ED Treatment Sales Volume by End User/Segment (2016-2021)
Table Asia Pacific ED Treatment Sales Volume Market Share by End User/Segment (2016-2021)
Table Central & South America ED Treatment Sales Volume by End User/Segment (2016-2021)
Table Central & South America Pacific ED Treatment Sales Volume Market Share by End User/Segment (2016-2021)
Table Middle East & Africa ED Treatment Sales Volume by End User/Segment (2016-2021)
Table Middle East & Africa ED Treatment Sales Volume Market Share by End User/Segment (2016-2021)
Table Global ED Treatment Sales Volume by Region (2016-2021)
Table Global ED Treatment Sales Volume Market Share by Region (2016-2021)
Table Global ED Treatment Sales Value by Region (2016-2021)
Table Global ED Treatment Value Market Share by Region (2016-2021)
Table North America ED Treatment Sales Volume by Country (2016-2021)
Table North America ED Treatment Sales Volume Market Share by Country (2016-2021)
Table Global ED Treatment Sales Value by Region/Country (2016-2021)
Table North America ED Treatment Value Market Share by Country (2016-2021)
Table Europe ED Treatment Sales Volume by Country (2016-2021)
Table Europe ED Treatment Sales Volume Market Share by Country (2016-2021)
Table Europe ED Treatment Sales Value by Country (2016-2021)
Table Europe ED Treatment Value Market Share by Country (2016-2021)
Table Asia Pacific ED Treatment Sales Volume by Country (2016-2021)
Table Asia Pacific ED Treatment Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific ED Treatment Sales Value by Country (2016-2021)
Table Asia Pacific ED Treatment Value Market Share by Country (2016-2021)
Table Central & South America ED Treatment Sales Volume by Country (2016-2021)
Table Central & South America ED Treatment Sales Volume Market Share by Country (2016-2021)
Table Central & South America ED Treatment Sales Value by Country (2016-2021)
Table Central & South America ED Treatment Value Market Share by Country (2016-2021)
Table Middle East & Africa ED Treatment Sales Volume by Country (2016-2021)
Table Middle East & Africa ED Treatment Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa ED Treatment Sales Value by Country (2016-2021)
Table Middle East & Africa ED Treatment Value Market Share by Country (2016-2021)
Table ED Treatment Raw Materials Key Suppliers List
Table ED Treatment Distributors List
Table ED Treatment Buyers List
Table Global ED Treatment Sales Volume Forecast by Category (2022-2027)
Table Global ED Treatment Sales Volume Market Share Forecast by Category (2022-2027)
Table Global ED Treatment Value Forecast by Category (2022-2027)
Table Global ED Treatment Value Market Share Forecast by Category (2022-2027)
Table Global ED Treatment Price Forecast by Category (2022-2027)
Table Global ED Treatment Sales Volume Forecast by End User/Segment (2022-2027)
Table Global ED Treatment Value Forecast by Category (2022-2027)
Table Global ED Treatment Value Forecast by End User/Segment (2022-2027)
Table Global ED Treatment Value Market Share Forecast by End User/Segment (2022-2027)
Table Global ED Treatment Price Forecast by End User/Segment (2022-2027)
Table Global ED Treatment Sales Volume Forecast by Region (2022-2027)
Table Global ED Treatment Value Forecast by End User/Segment (2022-2027)
Table Global ED Treatment Value Forecast by Region (2022-2027)
Table Global ED Treatment Value Market Share Forecast by Region (2022-2027)
Table Teva Pharma Company Information
Table Teva Pharma Product Introduction
Table Global ED Treatment Value Forecast by Region (2022-2027)
Table Seoul Pharma Company Information
Table Seoul Pharma Product Introduction
Table Seoul Pharma ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table S.K. Chemicals Company Information
Table S.K. Chemicals Product Introduction
Table S.K. Chemicals ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Metuchen Pharma Company Information
Table Metuchen Pharma Product Introduction
Table Metuchen Pharma ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Eli Lilly Company Information
Table Eli Lilly Product Introduction
Table Eli Lilly ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Dong-A ST Company Information
Table Dong-A ST Product Introduction
Table Dong-A ST ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table CSBIO. Company Information
Table CSBIO. Product Introduction
Table CSBIO. ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Bayer Company Information
Table Bayer Product Introduction
Table Bayer ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table BaiYunShan General Factory Company Information
Table BaiYunShan General Factory Product Introduction
Table BaiYunShan General Factory ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global ED Treatment Market Status and Forecast (2016-2027) 1.3.2 Global ED Treatment Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global ED Treatment Supply by Company 2.1 Global ED Treatment Sales Volume by Company 2.2 Global ED Treatment Sales Value by Company 2.3 Global ED Treatment Price by Company 2.4 ED Treatment Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional ED Treatment Market Status by Category 3.1 ED Treatment Category Introduction 3.1.1 Sildenafil 3.1.2 Tadalafil 3.1.3 Others 3.2 Global ED Treatment Market by Category 3.2.1 Global ED Treatment Sales Volume by Category (2016-2021) 3.2.2 Global ED Treatment Sales Value by Category (2016-2021) 3.2.3 Global ED Treatment Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional ED Treatment Market Status by End User/Segment 4.1 ED Treatment Segment by End User/Segment 4.1.1 Hospitals 4.1.2 Drugstores 4.1.3 Other 4.2 Global ED Treatment Market by End User/Segment 4.2.1 Global ED Treatment Sales Volume by End User/Segment (2016-2021) 4.2.2 Global ED Treatment Sales Value by End User/Segment (2016-2021) 4.2.3 Global ED Treatment Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global ED Treatment Market Status by Region 5.1 Global ED Treatment Market by Region 5.1.1 Global ED Treatment Sales Volume by Region 5.1.2 Global ED Treatment Sales Value by Region 5.2 North America ED Treatment Market Status 5.3 Europe ED Treatment Market Status 5.4 Asia Pacific ED Treatment Market Status 5.5 Central & South America ED Treatment Market Status 5.6 Middle East & Africa ED Treatment Market Status6 North America ED Treatment Market Status 6.1 North America ED Treatment Market by Country 6.1.1 North America ED Treatment Sales Volume by Country (2016-2021) 6.1.2 North America ED Treatment Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe ED Treatment Market Status 7.1 Europe ED Treatment Market by Country 7.1.1 Europe ED Treatment Sales Volume by Country (2016-2021) 7.1.2 Europe ED Treatment Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific ED Treatment Market Status 8.1 Asia Pacific ED Treatment Market by Country 8.1.1 Asia Pacific ED Treatment Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific ED Treatment Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America ED Treatment Market Status 9.1 Central & South America ED Treatment Market by Country 9.1.1 Central & South America ED Treatment Sales Volume by Country (2016-2021) 9.1.2 Central & South America ED Treatment Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa ED Treatment Market Status 10.1 Middle East & Africa ED Treatment Market by Country 10.1.1 Middle East & Africa ED Treatment Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa ED Treatment Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 ED Treatment Manufacturing Cost Analysis 11.5 ED Treatment Sales Channel and Distributors Analysis 11.5.1 ED Treatment Sales Channel 11.5.2 ED Treatment Distributors 11.6 ED Treatment Downstream Major Buyers12 Global ED Treatment Market Forecast by Category and by End User/Segment 12.1 Global ED Treatment Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global ED Treatment Forecast by Category 12.2.1 Global ED Treatment Sales Volume Forecast by Category 12.2.2 Global ED Treatment Sales Value Forecast by Category 12.2.3 Global ED Treatment Price Forecast by Category 12.3 Global ED Treatment Forecast by End User/Segment 12.3.1 Global ED Treatment Sales Volume Forecast by End User/Segment 12.3.2 Global ED Treatment Sales Value Forecast by End User/Segment 12.3.3 Global ED Treatment Price Forecast by End User/Segment13 Global ED Treatment Market Forecast by Region/Country 13.1 Global ED Treatment Market Forecast by Region (2022-2027) 13.1.1 Global ED Treatment Sales Volume Forecast by Region (2022-2027) 13.1.2 Global ED Treatment Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Teva Pharma 14.1.1 Company Information 14.1.2 ED Treatment Product Introduction 14.1.3 Teva Pharma ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Seoul Pharma 14.2.1 Company Information 14.2.2 ED Treatment Product Introduction 14.2.3 Seoul Pharma ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 S.K. Chemicals 14.3.1 Company Information 14.3.2 ED Treatment Product Introduction 14.3.3 S.K. Chemicals ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Pfizer 14.4.1 Company Information 14.4.2 ED Treatment Product Introduction 14.4.3 Pfizer ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Metuchen Pharma 14.5.1 Company Information 14.5.2 ED Treatment Product Introduction 14.5.3 Metuchen Pharma ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Eli Lilly 14.6.1 Company Information 14.6.2 ED Treatment Product Introduction 14.6.3 Eli Lilly ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Dong-A ST 14.7.1 Company Information 14.7.2 ED Treatment Product Introduction 14.7.3 Dong-A ST ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 CSBIO. 14.8.1 Company Information 14.8.2 ED Treatment Product Introduction 14.8.3 CSBIO. ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Bayer 14.9.1 Company Information 14.9.2 ED Treatment Product Introduction 14.9.3 Bayer ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 BaiYunShan General Factory 14.10.1 Company Information 14.10.2 ED Treatment Product Introduction 14.10.3 BaiYunShan General Factory ED Treatment Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology